Industry News
Alchemia set to receive share of profits from fondaparinux sales
Alchemia Limited (ASX:ACL) is due to start receiving a share of the profits from US sales of its anticoagulant product, generic fondaparinux. [ + ]
NSW Science and Engineering Awards open for nomination
Scientists and engineers in NSW should get their nominations in by 5pm, 31 August 2012 for the 2012 NSW Science and Engineering Awards to be in the running for the prizes, worth $55,000. [ + ]
CathRx borrows to cover short term expenses
CathRx (ASX:CXD) has taken a $1m loan to cover short term expenses until it can finalise a more substantial capital raising, due within a couple of months. [ + ]
Scientex launches its new website
Scientex’s new website, to be launched in August 2012, will allow website visitors to access product, technical and application information quickly and easily. [ + ]
NSW’s top scientists and researchers urged to nominate for $55,000 prize
Acting NSW Premier and Minister for Trade and Investment Andrew Stoner has called for nominations for the 2012 NSW Science and Engineering Awards to recognise and reward the state’s leading scientists, engineers and researchers. [ + ]
Osprey Medical packs $18m cash after IPO
Medical device company Osprey Medical (ASX:OSP) is still cashed up from its 20 million IPO on the ASX, despite recording a cash outflow for the June quarter of $1.4 million. [ + ]
“Australian 11” of medical research: GSK Award for Research Excellence finalists announced
A selection of Australia’s leading medical researchers have been declared finalists in the 2012 GlaxoSmithKline Award for Research Excellence, with the winner to be announced on September 11. [ + ]
Universal Biosensors gets second $1.5m payment
Universal Biosensors (ASX:UBI) has earned a second $1.5 million milestone payment from Siemens Healthcare, seven weeks after receiving the first. [ + ]
AAMRI calls for government to spur biotech commercialisation
The government has a significant role to play in helping Australia’s world class medical research be translated into genuine health and economic benefits, says the Association of Australian Medical Research Institutes (AAMRI). [ + ]
Technology partnership to tackle society’s big challenges
The University of Western Australia has teamed up with measurement technology company Agilent Technologies, committing to a five-year collaboration that will enable the development of groundbreaking applications in life sciences. [ + ]
Investment event of the year calls for expressions of interest
AusBiotech invites your expression of interest for the opportunity to present at the Australasian Life Science Investment Summit (ALSIS) 2012 as one of 40 of Australasia’s most promising biotechnology companies. [ + ]
BREVAGen receives approval to sell in California
Genetic Technologies (ASX:GTG) continues its push into the US with BREVAGen, with it gaining approval to sell into California. [ + ]
CoDa raises NZ$25m to fund wound treatment
NZ biotech CoDa Therapeutics has received a NZ$24.5 million funding injection from a Russian investor, to help continue commercialisation of wound therapy Nexagon. [ + ]
Tracing the ‘great, great grandmothers’ of the chicken world
Dr Alice Storey, an archaeologist at the University of New England, is tracing the global migration routes of domestic chickens back through thousands of years towards their origins in the jungles of South-East Asia. [ + ]
Mesoblast eyes human trials of stem cell treatment for rheumatoid arthritis
Animal trials of Mesoblast's (ASX:MSB) mesenchymal stem cells in rheumatoid arthritis (RA) have encouraged the company press on with an FDA application for a phase II trial. [ + ]
